Package 63323-120-20

Brand: cytarabine

Generic: cytarabine
NDC Package

Package Facts

Identity

Package NDC 63323-120-20
Digits Only 6332312020
Product NDC 63323-120
Product ID 63323-120_88adbc49-b19d-44af-8f0b-a563bbb02aec
Description

1 VIAL, SINGLE-DOSE in 1 CARTON (63323-120-20) / 20 mL in 1 VIAL, SINGLE-DOSE

Marketing

Marketing Status
Marketed Since 2004-11-29
Brand cytarabine
Generic cytarabine
Sample Package No

Linked Drug Pages (1)

Cytarabine ndc-match (0.95)

Raw FDA Data

View complete raw FDA NDC JSON payload 
{"route": ["INTRATHECAL", "INTRAVENOUS", "SUBCUTANEOUS"], "spl_id": "88adbc49-b19d-44af-8f0b-a563bbb02aec", "openfda": {"nui": ["N0000000233", "N0000175595"], "upc": ["0363323120207"], "unii": ["04079A1RDZ"], "rxcui": ["249364"], "spl_set_id": ["c4fdc56e-efd7-4825-a518-ef430b2b3df0"], "pharm_class_epc": ["Nucleoside Metabolic Inhibitor [EPC]"], "pharm_class_moa": ["Nucleic Acid Synthesis Inhibitors [MoA]"], "manufacturer_name": ["Fresenius Kabi USA, LLC"], "is_original_packager": [true]}, "finished": true, "packaging": [{"sample": false, "description": "1 VIAL, SINGLE-DOSE in 1 CARTON (63323-120-20)  / 20 mL in 1 VIAL, SINGLE-DOSE", "package_ndc": "63323-120-20", "marketing_start_date": "20041129"}], "brand_name": "Cytarabine", "product_id": "63323-120_88adbc49-b19d-44af-8f0b-a563bbb02aec", "dosage_form": "INJECTION, SOLUTION", "pharm_class": ["Nucleic Acid Synthesis Inhibitors [MoA]", "Nucleoside Metabolic Inhibitor [EPC]"], "product_ndc": "63323-120", "generic_name": "CYTARABINE", "labeler_name": "Fresenius Kabi USA, LLC", "product_type": "HUMAN PRESCRIPTION DRUG", "brand_name_base": "Cytarabine", "active_ingredients": [{"name": "CYTARABINE", "strength": "100 mg/mL"}], "application_number": "ANDA076512", "marketing_category": "ANDA", "marketing_start_date": "20041129", "listing_expiration_date": "20261231"}